Buymed Strengthens Strategic Partnerships with Leading Pharma Partners for 2026

Buymed strengthens strategic partnerships with leading pharmaceutical partners to build a sustainable healthcare ecosystem, advancing distribution excellence and ensuring accessible quality medicines across Vietnam in 2026 and beyond.

To kick off 2026, Buymed held a series of strategic discussions with our key partners: Merck, OPV, Vinh Phuc Pharmaceutical, Bidiphar, Sumitomo and Vidipha. These meetings served as a platform to reflect on past achievements and, more importantly, to chart a sustainable growth path for the coming year.

A Shared Vision: Modernizing the Healthcare Supply Chain

During discussions with Merck and OPV partners, Buymed focused on leveraging technology to enhance access to specialized medicines and high-quality healthcare products. The core objective is to bridge the gap between manufacturers and patients, ensuring that pharmacies nationwide can access transparent and reliable supplies efficiently.

With Vinh Phuc Pharmaceutical, Sumitomo and Bidiphar partners, both parties explored new solutions to improve the efficiency of the domestic supply chain. The synergy between their established manufacturing capabilities and Buymed's modern distribution platform is expected to drive breakthroughs in both scale and service quality.

A Symbol of Trust and Heritage

A highlight of this series was the meeting with Vidipha. To commemorate our long-standing partnership, Vidipha presented Buymed with a Dong Son bronze drum — a gift rich in cultural heritage, symbolizing absolute trust and a commitment to long-term collaboration.

Towards a Prosperous 2026

Buymed highly values the professionalism and vision of Merck, OPV, Vinh Phuc, Bidiphar, Sumitomo and Vidipha. The synergy of resources and technology between Buymed and these industry leaders is the key to building a sustainable healthcare ecosystem, delivering tangible benefits to the Vietnamese healthcare community in 2026 and beyond.